ARTICLE | Clinical News
Evista raloxifene regulatory update
March 10, 2014 7:00 AM UTC
FDA approved an ANDA from Teva Pharmaceutical Industries Ltd. (NYSE:TEVA, Petah Tikva, Israel) for its generic version of Eli Lilly's Evista raloxifene. Evista is approved to treat and prevent osteop...